Results 141 to 150 of about 16,238 (237)

Data from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial

Janghee Woo, Tingting Zhai, Fang Yang, Huilei Xu, Margaret L. Healey, Denise P. Yates, Michael T. Beste, David P. Steensma   +7 more
openalex   +1 more source

Response to: ‘Correspondence on ‘Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial“ by Satis et al [PDF]

, 2020
Seza Özen, Fabrizio De Benedetti
openalex   +1 more source

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis [PDF]

, 2013
PRINTO/PRCSG, Pierre Quartier, Hermine I. Brunner, T. Constantin, Shai Padeh, Inmaculada Calvo, Müferet Ergüven, Laurence Goffin, M Hofer, Tilmann Kallinich, S Oliveira, Yosef Uziel, Stefania Viola, Kiran Nistala, Carine Wouters, K. Lheritier, Josef Hruska, Kenneth Abrams, Alberto Martini, Nicolino Ruperto, D. Lovell   +20 more
openalex   +1 more source

Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab

, 2021
Amit Druyan, Eitan Giat, Avi Livneh, Chagai Grossman, Ilan Ben‐Zvi, Merav Lidar   +5 more
openalex   +2 more sources

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis. [PDF]

JBMR Plus
Dauchez A, Herrou J, Mihoubi-Bouvier F, Quartier P, Baujat G, Koumakis E, Briot K, Roux C.   +7 more
europepmc   +1 more source

Additional file 1: Table S1. of Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

, 2015
Ahmet GĂźl, Huri Ozdogan, Burak Erer, Serdal Ugurlu, Ozgur Kasapcopur, Nicole Davis, Serhan Sevgi   +6 more
openalex   +1 more source

Safety and Effectiveness of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan: A Post-Marketing Surveillance Study. [PDF]

Rheumatol Ther
Akita F, Seko N, Yoneda T.
europepmc   +1 more source

Evaluation of the Effect of IL-1 Antagonists on Pituitary Function. [PDF]

Int J Endocrinol
Aktas Koc F, Sariakcali B, Sahin A.
europepmc   +1 more source

Canakinumab for Residual Inflammatory Risk [PDF]

, 2017
Paul M. Ridker
openalex   +1 more source

Difficult-to-Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual-Inhibitor Therapy. [PDF]

ACR Open Rheumatol
Aljundi N, Piranavan P.
europepmc   +1 more source